Your browser doesn't support javascript.
loading
Body Mass Index As A Prognostic Factor In HER-2 Positive Early Breast Cancer Patients And Its Effect On Duration Of Treatment With Trastuzumab: A Retrospective Study.
Bardisi, Samaa AbdAlla; ElFeky, Amany Mostafa; Ibrahim, Eman Ismail; Dorgham, Yousra; Elmongy Sadaka, Emad Abd.
  • Bardisi SA; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt.
  • ElFeky AM; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt.
  • Ibrahim EI; Department of Clinical Oncology and Nuclear Medicine,Zagazig University,Egypt.
  • Dorgham Y; Department of Clinical Oncology and Nuclear Medicine,Zagazig University,Egypt.
  • Elmongy Sadaka EA; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt.
J Pak Med Assoc ; 73(Suppl 4)(4): S257-S262, 2023 Apr.
Article en En | MEDLINE | ID: mdl-37482869
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article